insights_auto
Why is PFIZ34 up 3,05%?
Dive Deeperchevron_right
PFIZ34:BVMF
Pfizer BDR
R$35,15
arrow_upward
+3,05%(+1,04) 1D
7 Okt., 17:05:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFIZ34...
Open
R$34,45
High
R$35,24
Low
R$34,38
Mkt. cap
159,59 mjd
Avg. vol.
8,32 k
Volume
20,89 k
52-wk high
R$37,70
52-wk low
R$30,09
Shares outstanding
5,70 mjd
No. of employees
75 k
Open
R$34,45
High
R$35,24
Low
R$34,38
Mkt. cap
159,59 mjd
Avg. vol.
8,32 k
Volume
20,89 k
52-wk high
R$37,70
52-wk low
R$30,09
Shares outstanding
5,70 mjd
No. of employees
75 k
News stories
From web sources and news partners
The Globe and Mail
·
21 minute gelede
Pfizer Stock: Buy, Sell, or Hold?
Insider Monkey
·
1 uur gelede
Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple?
Techi
·
2 uur gelede
Pfizer stock: FDA expands Tukysa’s breast cancer approval
Investing.com
·
8 uur gelede
Pfizer to cut 330 jobs at Sicily plant, unions say
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75 k
Founded1849
HeadquartersNew York Stad, New York, Verenigde State van Amerika
SectorPharmaceutical industry
Websitepfizer.com